Lin Chen | Materials Science | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Lin Chen | Materials Science | Best Researcher Award

Professor at Xi’an Jiaotong University, China

Prof. Lin Chen is a rising academic leader in the field of Materials Science and Engineering, with a focus on thermal protection coatings under extreme environments. With a prolific publishing record and multiple high-impact contributions to both fundamental and applied materials research, Prof. Chen has quickly established himself as a key figure in aerospace-related materials innovation. His work bridges theoretical design and practical application, contributing significantly to the development and successful deployment of advanced coating systems in China’s aerospace sector.

Publication Profile 

Scopus

Educational Background 🎓

  • Ph.D. in Materials Science and Engineering,
    Xi’an Jiaotong University (XJTU) — July 2020

Professional Experience 💼

  • Associate Professor, School of Materials Science and Engineering, XJTU — Present

  • Assistant Professor, Xi’an Jiaotong University — November 2020 – Present

  • Selected as an A-Class Young Talent at XJTU — 2020

  • Research supported by the National Postdoctoral Innovation Talent Support Program — 2021

Research Interests 🔬

Prof. Chen’s research primarily addresses the mechanical design and durability of thermal protection coatings, with emphasis on:

  • Stress-induced coating failure in oxide scales

  • Development of ultra-high-temperature, long-life coatings

  • Application of protective coatings in extreme aerospace engine environments, including high chamber pressure, high velocity, and elevated gas temperatures

  • Performance assessment through ground testing and design life validation

Awards and Honors🏆✨

  • A-Class Young Talents Program, Xi’an Jiaotong University — 2020

  • National Postdoctoral Innovation Talent Support Program — 2021

  • Three National Natural Science Foundation projects (as PI)

  • Key project from National Defense Science and Technology Laboratory

  • Seven collaborative projects with China Aerospace Science and Technology Corporation (CASC)

  • Publications Achievements:

    • 25 papers as first or corresponding author

    • Featured in Nature Biomedical Engineering and a Nature cover article

    • Two ESI Highly Cited Papers

    • Most-cited paper: 232+ citations

    • Total citations: 2,000+

    • H-index: 21

Conclusion🌟

Prof. Lin Chen exemplifies the next generation of materials scientists with a sharp focus on real-world challenges in thermal protection for aerospace applications. With his extensive publication record, competitive grant leadership, and successful industry collaborations, he has already made impactful strides in the materials community. His role in advancing high-performance coatings that withstand extreme conditions has not only contributed to academic knowledge but also enhanced the reliability and endurance of aerospace systems. He is a promising and influential scholar in China’s high-tech innovation landscape.

Publications 📚

📄 Article (Open Access)
🔬 High entropy engineering boosts thermo-mechanical properties of rare-earth tantalates: Influences of cocktail effects
👤 Luyang Zhang, Lin Chen, Jiankun Wang, Yanhui Chu, Jing Feng
📰 Journal of Materiomics, 2025
📈 Citations: 1

📄 Article
🔥 Promoting Yb₂Si₂O₇ environmental barrier coatings for service at 1425 °C
👤 Lin Chen, Shuwen Li, Chang-Jiu Li, Guanjun Yang
📰 Journal of the European Ceramic Society, 2025
📈 Citations: 1

📄 Article
🛡️ A4Ta2O9 (A=Ca, Mg) tantalate as novel thermal barrier coatings materials with superior CMAS resistance
👤 Luyang Zhang, Keren Luo, Lin Chen, Baihui Li, Jing Feng
📰 Journal of the European Ceramic Society, 2025
📈 Citations: 1

📄 Article (Open Access)
🏗️ Thermal/mechanical properties of cordierite synthesized using coal gangue as a refractory material
👤 Guangmao Yan, Lin Chen, Qingwei Jiang, Zulai Li, Jing Feng
📰 International Journal of Applied Ceramic Technology, 2025
📈 Citations: 0

📄 Article (Open Access)
💥 Reactive self-consumption strategy to suppress SiO₂ phase transition-induced cracking
👤 Lin Chen, Shuwen Li, Chang-Jiu Li, Qiang Zhang, Guanjun Yang
📰 Journal of Advanced Ceramics, 2025
📈 Citations: 0

📄 Article
🧪 Suppressing the oxygen-ionic conductivity and promoting the phase stability of high-entropy rare earth niobates via Ta substitution
👤 Mengdi Gan, Liping Lai, Jiankun Wang, Jing Feng, Xiaoyun Yu Chong
📰 Journal of Materials Science and Technology, 2025
📈 Citations: 17

📄 Article (Open Access)
🔍 Nanomechanical properties of RENbO₄ (RE = La, Gd, Dy, Y, Yb) ceramics: A nanoindentation study
👤 Xiang Jiang, Lin Chen, Di Zhang, Guiyu Xue, Jing Feng
📰 Journal of the American Ceramic Society, 2025
📈 Citations: 0

📄 Article
⚙️ Exceptional abrasion and corrosion resistance of NiCoCrAlY/Al₂O₃ blade tip abrasive coatings up to 1000 °C by laser cladding
👤 Lin Chen, Yuhao Xie, Chang-Jiu Li, Guanjun Yang
📰 Surface and Coatings Technology, 2025
📈 Citations: 1

📄 Article
🧱 Optimizations of thermal and mechanical properties of Al₁₋ₓMₓTaO₄ (M=Ga and Co) ceramics for thermal/environmental barrier coatings
👤 Luyang Zhang, Lin Chen, Yuxuan Zhang, Jiang Tian, Jing Feng
📰 Ceramics International, 2025
📈 Citations: 0

📄 Article
🌡️ Durable GdTaO₄/YSZ double-ceramic-layer thermal barrier coatings against ultrahigh-temperature thermal shock
👤 Guanjun Yang, Lin Chen
📰 Ceramics International, 2025
📈 Citations: 0

Yi Gou | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Mr. Yi Gou | Medicinal Chemistry | Best Researcher Award

Associate Researcher at Guilin Medical University, China

Yi Gou is a distinguished researcher in anticancer drug chemistry with a strong academic background and a track record of innovation. He has authored over 40 SCI papers, with a significant number of first-author publications. His groundbreaking research has led to multiple patents and contributions to international scientific literature. Yi has also served as a guest editor for renowned journals such as Frontiers in Pharmacology and Drug Development Research. His expertise and research are recognized globally, contributing to advancements in cancer therapy.

Publication Profile : 

Scopus

Educational Background 🎓

Yi Gou earned a Ph.D. in Inorganic Chemistry in 2016. During his doctoral research, he specialized in the field of anticancer drug chemistry, laying the foundation for his subsequent work. His extensive education and training have provided him with a solid understanding of both inorganic chemistry and medicinal chemistry, particularly in designing and synthesizing anticancer small molecule agents. This expertise has guided his research in the development of novel drug candidates, and his academic achievements include numerous publications in high-impact journals.

Professional Experience 💼

Yi Gou is currently serving as an Associate Researcher at Guilin Medical University, where he continues his pioneering research on anticancer drug chemistry. His professional career includes both independent research projects and collaborative work, notably contributing to the National Natural Science Foundation of China (NSFC) projects. He has led one completed NSFC project (Project No. 22007023) and is actively conducting another (Project No. 22267004). In addition to his research, Yi Gou has also been recognized for his editorial contributions, serving as a guest editor for journals such as Frontiers in Pharmacology and Drug Development Research. Over the years, his work has resulted in numerous publications, patents, and positive evaluations in the international research community.

Research Interests 🔬

Yi’s primary research focus is on the design and synthesis of small molecule anticancer agents, particularly those involving metal-based complexes. His work merges the fields of inorganic chemistry and medicinal chemistry, with a focus on developing novel therapeutics to combat cancer. Yi has received significant funding for his research, completing one National Natural Science Foundation of China project (Project No. 22007023) and currently leading another (Project No. 22267004). His work has led to eight Chinese invention patents and multiple collaborations, including research on metal-antitumor complexes based on traditional Chinese medicine components.

Key Achievements

🔬 Over 40 published SCI papers, with an h-index of 24
📜 8 Chinese invention patents granted, 6 in the process of application
🔗 Collaborations with leading researchers and national projects
🌍 Recognized as a guest editor for prominent journals
🎓 Member of the Chinese Chemical Society

Publications 📚

  • Li, A., Pan, W., Zhang, Z., Zhang, Y., & Ma, L. (2025). Hydrazone copper(II) complexes suppressed lung adenocarcinoma by activating multiple anticancer pathways. Bioorganic Chemistry, 154, 107994.
  • Li, A., Huang, K., Pan, W., Ma, L., & Gou, Y. (2024). Thiosemicarbazone mixed-valence Cu(I/II) complex against lung adenocarcinoma cells through multiple pathways involving cuproptosis. Journal of Medicinal Chemistry, 67(11), 9091–9103.

  • Wu, Y., Wu, D., Lan, J., Xu, Y., & Gou, Y. (2024). Assessment of mononuclear/dinuclear copper acylhydrazone complexes for lung cancer treatment. Bioorganic Chemistry, 144, 107122.

  • Deng, J., Wu, Y., Li, A., Yang, F., & Gou, Y. (2023). Dithiocarbazate-Zn(II) complexes for photodynamic therapy and chemotherapy against lung cancer. Inorganic Chemistry Frontiers, 10(22), 6526–6536.

  • Wu, Y., Hou, L., Lan, J., Liu, W., & Gou, Y. (2023). Mixed-ligand copper(II) hydrazone complexes: Synthesis, structure, and anti-lung cancer properties. Journal of Molecular Structure, 1279, 134986.
  • Gou, Y., Liu, L., & Liang, H. (2022). Editorial: The developments of metal-based agents against lung cancer. Frontiers in Pharmacology, 13, 1101890.
  • Chen, M., Chen, X., Huang, G., Gou, Y., & Deng, J. (2022). Synthesis, anti-tumour activity, and mechanism of benzoyl hydrazine Schiff base-copper complexes. Journal of Molecular Structure, 1268, 133730.
  • Deng, J., Peng, C., Hou, L., Huang, G., & Gou, Y. (2022). Dithiocarbazate-copper complex loaded thermosensitive hydrogel for lung cancer therapy via tumor in situ sustained-release. Inorganic Chemistry Frontiers, 9(23), 6190–6201.
  • Guo, J., Li, A., Guo, R., Jin, J., & Huang, G. (2022). C1orf74 positively regulates the EGFR/AKT/mTORC1 signaling in lung adenocarcinoma cells. PeerJ, 10, e13908.
  • Gou, Y., Jia, X., Hou, L. X., Jiang, H. W., & Yang, F. (2022). Dithiocarbazate-Fe(III), -Co(III), -Ni(II), and -Zn(II) complexes: Design, synthesis, structure, and anticancer evaluation. Journal of Medicinal Chemistry, 65(9), 6677–6689.

 

 

 

Prabhjyoti Pahwa | Immunology | Best Researcher Award

Posted on by sciencefather

Ms. Prabhjyoti Pahwa | Immunology | Best Researcher Award

Ph.D. Student at Institute of Liver and Biliary Sciences, India

Prabhjyoti Pahwa is a dedicated Ph.D. scholar at the Institute of Liver and Biliary Sciences, New Delhi, with a focus on immunology and liver diseases. Her work spans a wide range of research areas, from viral infections to immune-metabolic responses in liver disease pathogenesis. She has actively contributed to multiple peer-reviewed publications in leading journals, particularly exploring immune alterations in diseases like Hepatitis E and B, as well as in COVID-19 during pregnancy. As a researcher, she combines a strong technical skillset in molecular biology and cell biology with a passion for understanding the immune system’s role in liver diseases. Prabhjyoti is committed to advancing the field of hepatology through innovative research, with a vision to improve maternal and fetal health outcomes in viral infections.

Publication Profile : 

Scopus

Educational Background 🎓

  • Ph.D. (2022 – Present)
    Institute of Liver and Biliary Sciences, New Delhi
  • Junior Research Fellow (2020 – 2022)
    Institute of Liver and Biliary Sciences, New Delhi
  • M.Sc. in Biotechnology (2017 – 2019)
    Panjab University, Chandigarh
    GPA: 3.45 (86.24%)
  • B.Sc. in Zoology (Hons.) (2014 – 2017)
    Zakir Husain Delhi College, University of Delhi
    GPA: 3.199 (79.99%)
  • Intermediate (Class 12, 2014)
    RPVV Raj Niwas Marg, Delhi
    80.04%
  • Matriculation (Class 10, 2012)
    B.M. Ganges Girls’ Senior Secondary School, Delhi
    CGPA: 8.2

Professional Experience 💼

Prabhjyoti Pahwa is currently a Junior Research Fellow and Ph.D. Scholar at the Institute of Liver and Biliary Sciences (ILBS), New Delhi, where she has been conducting cutting-edge research on hepatology and immunology since 2020. Her research focuses on Hepatitis E Virus (HEV) infection during pregnancy and its severe maternal and fetal outcomes, as well as the immune-metabolic shifts in various liver diseases, including Hepatitis B and C. Throughout her research career, she has worked under the mentorship of Prof. Nirupama Trehanpati and collaborated with prominent researchers in the field of liver diseases. Previously, she was a Master’s student at Panjab University, Chandigarh, where she gained practical experience in biotechnology, cell biology, and molecular techniques. She has also worked on several collaborative projects, contributing to a diverse range of research topics, from lipase-producing bacteria to biosensors for pesticide detection.

Research Interests 🔬

Prabhjyoti’s primary research interests include:

  • Hepatitis E virus (HEV) and its impact during pregnancy
  • Immuno-metabolic shifts in liver diseases, especially in pregnant women with viral infections
  • The role of T cells, natural killer cells, and cytokines in the progression of liver diseases like hepatitis B
  • Single-cell RNA sequencing for exploring immune responses in chronic viral infections
  • Investigating metabolomic alterations and their correlation with disease severity in liver diseases and SARS-CoV-2 infections during pregnancy.

Publications 📚

  1. Prabhjyoti Pahwa, Deepti Sharma*, Pushpa Yadav, Sherin Sarah Thomas, Sandhya Hora, Preedia Babu E., Gayatri Ramakrishna, Shiv Kumar Sarin*, Nirupama Trehanpati*.
    Prognostic role of serum VEGF and HGF post SBRT in advanced hepatocellular carcinoma.
    Journal of Clinical and Experimental Hepatology, 2024 (Accepted in October 2024).

  2. Anoushka Saxena, Minal, Prabhjyoti Pahwa, Jaswinder Singh Maras, Hamda Siddiqui, Jayesh Kumar Sevak, Y.M. Mala, Shakun Tyagi, Shiv Kumar Sarin, Nirupama Trehanpati.
    Immuno-metabolic shifts in acute liver failure caused by hepatitis E virus infection during pregnancy and their association with obstetric outcomes.
    Hepatology Communication, 2024 (Accepted in October 2024).

  3. Prabhjyoti Pahwa, Ashish Kumar Vyas, Jayesh Kumar Sevak, Ravinder Singh, Jaswinder Singh Maras, Sharda Patra, Shiv K Sarin, Nirupama Trehanpati*.
    Modulation of CD8+ T cells, natural killer cells and Th1 cytokines by metabolic milieu in decline of HBV viremia in pregnant women treated with Tenofovir disoproxil from second trimester of pregnancy.
    Journal of Reproductive Immunology, 2024, Volume 162.

  4. Sandhya Hora$, Prabhjyoti Pahwa$, Hamda Siddiqui, Anoushka Saxena, Minal Kashyap, Jayesh Kumar Sevak, Ravinder Singh, Maryam Javed, Pushpa Yadav, Pratibha Kale, Gayatri Ramakrishna, Meenu Bajpai, Asmita Rathore, Jaswinder Singh Maras, Shakun Tyagi*, Shiv Kumar Sarin*, Nirupama Trehanpati*.
    Metabolic alterations unravel the materno–fetal immune responses with disease severity in pregnant women infected with SARS-CoV-2.
    Journal of Medical Virology, December 2023, Volume 95, Issue 12.
    DOI: 10.1002/jmv.29257.

  5. Prabhjyoti Pahwa1, Ravinder Singh1, Partha Chattopadhyay2, Priyanka Mehta2, Sharda Patra3, Rajesh Pandey2, Shakun Tyagi4, Shiv Kumar Sarin5*, Nirupama Trehanpati1*.
    Single cell RNA sequencing reveals exhausted adaptive immunity in utero to HBV exposed neonates born to mothers with high HBsAg titres persisting despite vaccination.
    Hepatology, AASLD 2024, Poster of Distinction.

  6. Prabhjyoti Pahwa, Fatima Ali, Ashish Kumar Vyas, Sharda Patra, Shiv K Sarin, Nirupama Trehanpati*.
    Decline in viral load induces CD8+ T cells, natural killer cells and Th1 cytokine profile in chronic hepatitis B infected pregnant women treated with Tenofovir disoproxil from second trimester.
    Oral Presentation, AASLD 2022.

  7. Anoushka Saxena, Hamda Siddiqui, Jayesh Kumar Sevak, Minal, Prabhjyoti Pahwa, Fatima Ali, Shakun Tyagi, Shiv Kumar Sarin, Nirupama Trehanpati*.
    IL-7 induced CD4+ Memory stem T cell-derived pro-inflammatory cytokine storm plays a role in hepatitis E induced pathogenesis in pregnant women.
    AASLD 2022.

  8. Anoushka Saxena, Minal Kashyap, Prabhjyoti Pahwa, Fatima Ali, Hamda Siddiqui, Preedia Babu E., Y.M. Mala, Shakun Tyagi, Nirupama Trehanpati.
    Elevated serum bilirubin levels and aminotransferases are associated with immuno-modulatory and suppressive subsets in pregnant females with intrahepatic cholestasis and hepatitis E virus infection.
    EASL 2022.

  9. Anoushka Saxena, Prabhjyoti Pahwa, Hamda Siddiqui, Jaswinder Singh Maras, Rashi Sehgal, Sharda Patra, Shiv Kumar Sarin, Nirupama Trehanpati.
    The metabolome profiling of patients infected with hepatitis E virus unravels the role of Nicotinate and Nicotinamide pathway and D-glutamine and glutamate metabolism in the development of Acute Liver Failure.
    AASLD 2021.

  10. Prabhjyoti Pahwa, Hamda Siddiqui, Fatima Ali, Jayesh Kumar Sevak, Archana Rastogi, Sakshi Aggarwal, Shakun Tyagi, Nirupama Trehanpati, Asmita Rathore.
    Rise in pro- and anti-inflammatory cytokines in asymptomatic and mild COVID-19 pregnant patients than moderate to severe patients.
    AOGD 2021.